Sanofi SNY
NASDAQ SNY
$39.92 -0.75 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Sanofi (SNY) recorded Return on Capital Employed [ROCE] of 3.31% in the quarter ended Jun 30, 2026, down 4.68 percentage points from 7.99% a year earlier.

Analysis

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2023, Sanofi reported Return on Capital Employed [ROCE] of 6.91%.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +1.37 percentage points (years ended Dec 2018 to Dec 2023).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 8.64% in the year ended Dec 31, 2021 (-27.79 pp), 36.44% in the year ended Dec 31, 2020 (+30.96 pp) and 5.48% in the year ended Dec 31, 2019 (-0.06 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Sanofi 48.68 Bn 15.46 Bn 10.79 Bn 3.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.31%
Dec 31, 2025 3.52%
Jun 30, 2025 7.99%
Dec 31, 2018 12.43%
Sep 30, 2018 9.83%
Mar 31, 2018 5.92%
API Access

Sanofi Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY